English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 40 Help

Selected(0)Clear Items/Page:    Sort:
Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis. Journal article
Wang MengFei, Yuan ChenYue, Wu Zong, Xu Meng, Chen ZiQi, Yao JiaLiang, Que ZuJun, Tian JianHui, Leung Elaine Lai Han, Wang ZiLiang. Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis.[J]. International Journal of Biological Sciences, 2024, 20(7), 2454-2475.
Authors:  Wang MengFei;  Yuan ChenYue;  Wu Zong;  Xu Meng;  Chen ZiQi; et al.
Adobe PDF | Favorite | TC[WOS]:1 TC[Scopus]:1  IF:8.2/8.3 | Submit date：2024/06/10
Angiogenesis  Ecm1  Glycolysis  Ovarian Cancer  Paris Saponin Vii  Parpi Resistance  Rorα  Vegfr2  
Editorial: Community series in novel insights into immunotherapy targeting tumor microenvironment in ovarian cancer: volume I Other
2023-04-11
Authors:  Di,Xiang Jie;  Zhao,Qi;  Wang,Hai Tao;  Wei,Xia Wei;  Liang,Xiao
Favorite | TC[WOS]:1 TC[Scopus]:1 | Submit date：2023/08/03
Exosomes  Immunotherapy  Non-tumor Cells Targeting  Ovarian Cancer  Tumor Immune Microenvironment  
Metabolic modulation of CtBP dimeric status impacts the repression of DNA damage repair genes and the platinum sensitivity of ovarian cancer Journal article
Li,Jingjing, Wang,Yuan, Wang,Li, Hao,Dapeng, Li,Peipei, Su,Minxia, Zhao,Zhiqiang, Liu,Tianyu, Tai,Lixin, Lu,Jinjian, Di,Li Jun. Metabolic modulation of CtBP dimeric status impacts the repression of DNA damage repair genes and the platinum sensitivity of ovarian cancer[J]. International journal of biological sciences, 2023, 19(7), 2081-2096.
Authors:  Li,Jingjing;  Wang,Yuan;  Wang,Li;  Hao,Dapeng;  Li,Peipei; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:8.2/8.3 | Submit date：2023/08/03
Cisplatin  Ctbp  Drug Resistance  Metformin  Ovarian Cancer  
Integrative analysis deciphers the heterogeneity of cancer-associated fibroblast and implications on clinical outcomes in ovarian cancers Journal article
Zhao, Yan, Mei, Song, Huang, Yixuan, Chen, Junru, Zhang, Xinlei, Zhang, Peng. Integrative analysis deciphers the heterogeneity of cancer-associated fibroblast and implications on clinical outcomes in ovarian cancers[J]. Computational and Structural Biotechnology Journal, 2022, 20, 6403-6411.
Authors:  Zhao, Yan;  Mei, Song;  Huang, Yixuan;  Chen, Junru;  Zhang, Xinlei; et al.
Favorite | TC[WOS]:13 TC[Scopus]:13  IF:4.4/5.0 | Submit date：2023/01/30
Bio-marker  Cafs  Gene Signature  Immunotherapy  Ovarian Cancer  Prognosis  Single-cell Sequencing  
A tRNA-derived fragment from Chinese yew suppresses ovarian cancer growth via targeting TRPA1 Journal article
Cao, Kai Yue, Yan, Tong Meng, Zhang, Ji Zhou, Chan, Ting Fung, Li, Jie, Li, Chong, Lai-Han Leung, Elaine, Gao, Jin, Zhang, Bao Xian, Jiang, Zhi Hong. A tRNA-derived fragment from Chinese yew suppresses ovarian cancer growth via targeting TRPA1[J]. Molecular Therapy - Nucleic Acids, 2022, 27, 718-732.
Authors:  Cao, Kai Yue;  Yan, Tong Meng;  Zhang, Ji Zhou;  Chan, Ting Fung;  Li, Jie; et al.
Favorite | TC[WOS]:20 TC[Scopus]:21 | Submit date：2022/09/21
Ovarian Cancer  Taxus Chinensis  Trf  Trna  Trpa1  
Molecular mechanism of Spatholobi Caulis in treatment of ovarian cancer based on network pharmacology and experimental verification 基于网络药理学和实验验证分析鸡血藤治疗卵巢癌的分子机制 Journal article
Zhu, Shi Chun, Cai, Jun, Wu, Cheng Yu, Cheng, Chun Song. Molecular mechanism of Spatholobi Caulis in treatment of ovarian cancer based on network pharmacology and experimental verification 基于网络药理学和实验验证分析鸡血藤治疗卵巢癌的分子机制[J]. Zhongguo Zhongyao Zazhi, 2022, 47(3), 786-795.
Authors:  Zhu, Shi Chun;  Cai, Jun;  Wu, Cheng Yu;  Cheng, Chun Song
Favorite | TC[Scopus]:3 | Submit date：2023/01/30
Molecular docking  Network pharmacology  Ovarian cancer  Prunetin  Spatholobi Caulis  
Nuclear hkii–p-p53 (Ser15) interaction is a prognostic biomarker for chemoresponsiveness and glycolytic regulation in epithelial ovarian cancer Journal article
Han, Chae Young, Patten, David A., Kim, Se Ik, Lim, Jung Jin, Chan, David W., Siu, Michelle K.Y., Han, Youngjin, Carmona, Euridice, Parks, Robin J., Lee, Cheol, Di, Li Jun, Lu, Zhen, Chan, Karen K.L., Ku, Ja Lok, Macdonald, Elizabeth A., Vanderhyden, Barbara C., Mes-Masson, Anne Marie, Ngan, Hextan Y.S., Cheung, Annie N.Y., Song, Yong Sang, Bast, Robert C., Harper, Mary Ellen, Tsang, Benjamin K.. Nuclear hkii–p-p53 (Ser15) interaction is a prognostic biomarker for chemoresponsiveness and glycolytic regulation in epithelial ovarian cancer[J]. Cancers, 2021, 13(14), 3399.
Authors:  Han, Chae Young;  Patten, David A.;  Kim, Se Ik;  Lim, Jung Jin;  Chan, David W.; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:4.5/4.9 | Submit date：2021/12/08
Cancer Metabolism  Chemoresistance  Epithelial Ovarian Cancer  Hexokinase Ii  P-p53 (Ser15)  
Dietary compound glycyrrhetinic acid suppresses tumor angiogenesis and growth by modulating antiangiogenic and proapoptotic pathways in vitro and in vivo Journal article
Li,Jingjing, Tang,Fan, Li,Renkai, Chen,Zhejie, Lee,Simon Ming Yuen, Fu,Chaomei, Zhang,Jinming, Leung,George Pak Heng. Dietary compound glycyrrhetinic acid suppresses tumor angiogenesis and growth by modulating antiangiogenic and proapoptotic pathways in vitro and in vivo[J]. Journal of Nutritional Biochemistry, 2020, 77.
Authors:  Li,Jingjing;  Tang,Fan;  Li,Renkai;  Chen,Zhejie;  Lee,Simon Ming Yuen; et al.
Favorite | TC[WOS]:31 TC[Scopus]:33  IF:4.8/5.4 | Submit date：2021/03/01
Antiangiogenesis  Apoptosis  Dietary Compound  Glycyrrhetinic Acid  Ovarian Cancer  
Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome Journal article
HAO, DP, LI, JJ, WANG, JL, ZHAO, ZQ, Wang, L., Di, L.. Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome[J]. Theranostics, 2019, 3952-3965.
Authors:  HAO, DP;  LI, JJ;  WANG, JL;  ZHAO, ZQ;  Wang, L.; et al.
Favorite |   IF:12.4/12.0 | Submit date：2023/08/30
Ovarian cancer  Estrogen signaling  Deficiency of homologous-recombination  Chemotherapy  Hormone replacement  
FAM83D promotes ovarian cancer progression and its potential application in diagnosis of invasive ovarian cancer Journal article
Qingyu Zhang, Shan Yu, Samson Ian Sam Lok, Alice Sze Tsai Wong, Yufei Jiao, Leo Tsz On Lee. FAM83D promotes ovarian cancer progression and its potential application in diagnosis of invasive ovarian cancer[J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23(7), 4569-4581.
Authors:  Qingyu Zhang;  Shan Yu;  Samson Ian Sam Lok;  Alice Sze Tsai Wong;  Yufei Jiao; et al.
Favorite | TC[WOS]:16 TC[Scopus]:14 | Submit date：2020/05/15
Fam83d  Nvasive Epithelial Ovarian Cancer,  Low Malignant Potential Ovarian Tumour  Molecular Diagnosis